SANOFI INDIA LIMITED·PHARMACEUTICALS 70.24·Pharmaceuticals & Biotechnology Companies

Price

3,352.8

+0.95%
O:3321
H:3372
L:3310
C:3352.8

52W Range

30545291
+10%/-37%

Market Cap

₹7,721.71 Cr

Traded: ₹5.98 Cr (0.08%) 0.0x

Free Float: ₹991.47 Cr (0.60% of FF traded)

Volume · 60D trend

17.86 K 0.0x

Delivery: % 0.0x

View Delivery Data

Returns

1W:+0% 1M:+1% 3M:+0% 6M:-6% 12M:-21%

Valuation

P/E18.7
P/B9.0
P/S3.8
EV/EBIT28.0

Business Strength

ROE47.1%
ROCE49.2%
OPM24.4%
NPM20.5%

Growth (3Y CAGR)

EPS-31.4%
Sales--
Profit--
3Y Return-10.0%

Balance Sheet

Debt/Equity0.0
Debt0 Cr
Pledge0.0%
CWIP/Fixed Asset5.8%

Cash Position

CFO/NP111.9%
FCF426 Cr
FCF 3Y Avg--
Cash/MCap5.0%

Others

Div Yield1.9%
Div Payout65.0%
Cash Conv. Cycle77 days
Tradeable Free Float12.8%

MTF Exposure Trend

60 sessions · funded amount, % of FF, daily delta

Current
₹ 34.45 Cr
3.47% FF
60d high
₹ 42.39 Cr
60d low
₹ 31.44 Cr
60d mean
₹ 35.34 Cr
vs mean
▼ 2.53%

Growth Trends

Metric10Y5Y3Y1YTTMTrend
Sales
--
--
--
--
+1.0%
--
ROE
--
--
--
--
--
--
Return
+2.0%
-8.0%
-10.0%
-48.0%
--
Decelerating
Profit
--
--
--
--
-25.0%
--

Quarterly Results

Dec 2024

PDF
Rev
515 Cr
+10% YoY-2% QoQ
OPM23.0%
NPM17.7%
PAT
+22% YoY91 Cr
EPS
-34% YoY39.7

Sep 2024

PDF
Rev
524 Cr
+7% YoY+13% QoQ
OPM23.0%
NPM15.7%
PAT
+2% YoY82 Cr
EPS
-46% YoY35.7

Jun 2024

PDF
Rev
464 Cr
-10% YoY-9% QoQ
OPM25.0%
NPM22.2%
PAT
+15% YoY103 Cr
EPS
-16% YoY44.9

Mar 2024

PDF
Rev
511 Cr
--+9% QoQ
OPM27.0%
NPM26.8%
PAT
--137 Cr
EPS
--59.4

Dec 2023

PDF
Rev
469 Cr
---4% QoQ
OPM21.0%
NPM29.4%
PAT
--138 Cr
EPS
--59.9

Sep 2023

PDF
Rev
491 Cr
---5% QoQ
OPM23.0%
NPM31.0%
PAT
--152 Cr
EPS
--66.0

Jun 2023

PDF
Rev
515 Cr
----
OPM24.0%
NPM23.9%
PAT
--123 Cr
EPS
--53.4

Revenue & Margin Trends

Annual

Quarterly

Balance Sheet Health

Leverage

Debt / Equity0.02
Interest Coverage3.5x
Promoter Pledge0.0%
Borrowings19 Cr

Efficiency

Receivable Days42 days
Inventory Days186 days
Payable Days151 days
Cash Conversion cycle77 days

Cash Position

Operating Cash Flow462 Cr
Investing Cash Flow-180 Cr
Financing Cash Flow-392 Cr
Free Cash Flow426 Cr

Detailed Financials

Dec 2024PDF ↗
Sep 2024PDF ↗
Jun 2024PDF ↗
Mar 2024PDF ↗
Dec 2023PDF ↗
Sep 2023PDF ↗
Jun 2023PDF ↗
Sales515524464511469491515
Expenses397404348374370377393
Operating Profit118120116137100114122
OPM %23.0%23.0%25.0%27.0%21.0%23.0%24.0%
Other Income1422141778257
Interest0000001
Depreciation10999999
Profit Before Tax122113127169167186169
Tax %25.0%27.0%19.0%19.0%18.0%18.0%27.0%
Net Profit9182103137138152123
Exceptional Items801638687142
EPS (Rs)39.735.744.959.459.966.053.4
Sales Growth (YoY)9.7%6.8%-10.0%--------
Sales Growth (QoQ)-1.7%12.9%-9.2%9.0%-4.5%-4.7%--
OP Growth (YoY)18.0%5.3%-4.9%--------
OP Growth (QoQ)-1.7%3.4%-15.3%37.0%-12.3%-6.6%--
Profit Growth (YoY)22.0%2.0%15.0%--------
EPS Growth (YoY)-33.7%-45.9%-16.0%--------
EPS Growth (QoQ)11.1%-20.4%-24.4%-0.8%-9.3%23.6%--
OP Margin22.9%22.9%25.0%26.8%21.3%23.2%23.7%
Net Margin17.7%15.7%22.2%26.8%29.4%31.0%23.9%
Material Cost %48.5%49.6%47.7%48.6%46.8%48.7%49.8%
Employee Cost %10.4%10.8%13.0%13.6%15.4%14.6%13.6%
P/S3.83------------
P/E18.66------------
P/B8.97------------

Shareholding Pattern

Shareholders:75.8K (-1.2%)
Current MixMar 2026

Exchange Filings

50
Company Update13 Aug 2026

Kindly refer the attachment

Company Update11 Aug 2026

Kindly refer the attachment

Company Update10 Aug 2026

Kindly refer the attachment.

Result04 Aug 2026

Kindly refer the attachment

Board Meeting04 Aug 2026

Kindly refer the attachment

Company Update23 Jul 2026

Kindly refer the attachment

Company Update23 Jul 2026

Kindly refer the attachment

Company Update23 Jul 2026

Kindly refer the attachment

Company Update23 Jul 2026

Kindly refer the attachment

Company Update23 Jul 2026

Kindly refer the attachment.

Board Meeting20 Jul 2026

Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....

Company Update07 Jul 2026

Please find enclosed certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June 2026.

Company Update03 Jul 2026

Please find enclosed disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Insider Trading / SAST26 Jun 2026

Kindly refer the attachment

Company Update24 Jun 2026

Please find enclosed disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Company Update09 Jun 2026

Please find enclosed disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Company Update27 May 2026

Please find enclosed intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Company Update20 May 2026

Please find enclosed copies of the Newspaper publication regarding the information on special window for transfer and dematerialisation of physical shares.

Company Update30 Apr 2026

Please find enclosed Press Release dated 30th April 2026

Company Update29 Apr 2026

Please find enclosed copies of the Newspaper Publication of Financial Results for quarter ended 31st March 2026, as published in Business Standard (English) and Sakal (Marathi) today i.e. ....

AGM/EGM29 Apr 2026

Please find enclosed proceedings of 70th Annual General Meeting.

AGM/EGM29 Apr 2026

Please find enclosed Scrutinizers Report on 70th Annual General Meeting.

Result28 Apr 2026

Please find enclosed a copy of Unaudited Financial Results for the quarter ended 31st March 2026

Company Update28 Apr 2026

Press Release dated 28th April 2026 enclosed.

Board Meeting28 Apr 2026

Please find enclosed a copy of the Unaudited Financial Results for the Quarter ended 31st March 2026

Company Update28 Apr 2026

Kindly refer the attachment.

Company Update21 Apr 2026

Kindy refer the attachment

Board Meeting20 Apr 2026

Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....

Company Update09 Apr 2026

MUFG Intime India Private Limited (formerly known as Link Intime India Private Limited), Registrar and Share Transfer Agent (RTA) of the Company has provided the enclosed certificate for ....

Company Update03 Apr 2026

Please find enclosed copies of Newspaper publications.

Others02 Apr 2026

Please refer the attachment

AGM/EGM02 Apr 2026

Please refer the attachment

Others02 Apr 2026

Please refer the attachment

Company Update02 Apr 2026

Please refer the attachment

Company Update02 Apr 2026

Please refer the attachment

Company Update02 Apr 2026

Please refer the attachment

Company Update31 Mar 2026

Please find enclosed Newspaper Advertisement regarding 70th Annual General Meeting and Opening of another Special Window for re-lodgement of transfer requests of physical shares.

Company Update28 Mar 2026

Please find enclosed intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Company Update25 Mar 2026

Please refer the attachment

AGM/EGM25 Mar 2026

Please refer the attachment

Corp. Action25 Mar 2026

Please refer the attachment

Corp. Action25 Mar 2026

Please refer the attachment

Company Update24 Mar 2026

We would like to inform you that pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the officials of the Company ....

Insider Trading / SAST24 Mar 2026

Intimation for closure of Trading Window for the quarter ending 31st March 2026

Company Update14 Mar 2026

Please find enclosed copies of newspaper advertisement regarding notice to the shareholders whose shares are liable to be transferred to the Investor Education and Protection Fund (IEPF) Authority.

Company Update05 Mar 2026

Please find enclosed transcript of Investor/ Analysts call held on 26th February 2026

Company Update27 Feb 2026

This is to inform you that the Audio-Video recording of the Investors/Analysts Call held on 26th February 2026 at 4:00pm for discussion on Financial Results for the quarter and year ended ....

Company Update26 Feb 2026

Please find enclosed Annual Secretarial Compliance Report for the year ended 31st December 2025.

Company Update26 Feb 2026

Please find enclosed copies of the Newspaper Publication of Financial Results for the quarter and year ended 31st December, 2025 of the Company published on 26th February 2026, in Business ....

Company Update26 Feb 2026

Please find enclosed presentation that will be made at the investor call.

Annual Reports

15

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

Concalls

12

Mar 2026

31 Mar 2026

Nov 2025

30 Nov 2025

May 2024

31 May 2024

Feb 2024

29 Feb 2024

Feb 2024

29 Feb 2024

Nov 2023

30 Nov 2023

Nov 2023

30 Nov 2023

May 2023

31 May 2023

May 2023

31 May 2023

Feb 2023

28 Feb 2023

Feb 2023

28 Feb 2023

Mar 2021

31 Mar 2021

Held by ETFs

1 ETFs hold SANOFI · sorted by weight

#ETFWeight %
1

MOHEALTH

MOTILALAMC - MOHEALTH

0.18%

Held by Mutual Funds

16 schemes hold SANOFI · sorted by weight

#SchemeWeight %
1

Nippon India Pharma Fund

Nippon India Mutual Fund

0.83%
2

Bandhan Healthcare Fund

Bandhan Mutual Fund

1.27%
3

Sundaram Dividend Yield Fund

Sundaram Mutual Fund

0.47%
4

Nippon India Innovation Fund

Nippon India Mutual Fund

0.54%
5

Aditya Birla Sun Life Balanced Advantage Fund

Aditya Birla Sun Life Mutual Fund

0.35%
6

Aditya Birla Sun Life Dividend Yield Fund

Aditya Birla Sun Life Mutual Fund

0.46%
7

Aditya Birla Sun Life Equity Hybrid '95 Fund

Aditya Birla Sun Life Mutual Fund

0.22%
8

Aditya Birla Sun Life Large Cap Direct Fund

Aditya Birla Sun Life Mutual Fund

0.29%
9

Bandhan BSE Healthcare Index Fund

Bandhan Mutual Fund

0.20%
10

SBI Contra Direct Plan-Growth

SBI Mutual Fund

0.16%
11

SBI ELSS Tax Saver Fund

SBI Mutual Fund

0.16%
12

Tata Ethical Direct Plan-Growth

Tata Mutual Fund

0.21%
13

Nippon India Growth Mid Cap Fund

Nippon India Mutual Fund

0.12%
14

Motilal Oswal BSE 1000 Index Fund

Motilal Oswal Mutual Fund

0.01%
15

Quant Small Cap Fund

Quant Mutual Fund

0.06%
16

Nippon India Small Cap Fund

Nippon India Mutual Fund

0.21%